Work

Immune-based therapies for hepatocellular carcinoma

Year: 2020
Type: review
Abstract: Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer-related death. The immune-rich contexture of the HCC microenvironment makes this tumour an appealing target for immune-based therapies. Here, we discuss how the functional characteristics of the liver microenvironment can potentially be harnessed for the treatment of HCC. We will review the evidence supporting a therapeutic role for vaccines, cell-based therapies and immune-checkpoint inhibitors and discuss the potential for patient stratification in an attempt to overcome the series of failures that has characterised drug development in this disease area.
Source: Oncogene
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W3012211502
FWCI: 4.101
Cites: 175
Cited by: 219
Related to: 10